Table 1.
Prevalence of Type 2 Diabetes Mellitus Among Men in Middle East Countries.
| Country | Author/year of Publication | Urban/Rural | Sample Size | Age (years) | Prevalence % |
|---|---|---|---|---|---|
| GCC states in the Middle East | |||||
| Bahrain | Aloia and Jassim (2017) | U/R | 501 | ≥20 | 33.60 |
| Saudi Arabia | Al-Rubeaan et al. (2015) | U/R | 25,884 | >30 | 29.10 |
| UAE | Sulaiman et al. (2018) | U/R | 449 | >18 | 25.83 |
| Kuwait | Channanath, Farran, Behbehani, and Thanaraj (2013) | U/R | 270,172 | 30–60 | 25.40 |
| Qatar | Bener et al. (2009) | U/R | 571 | 20–59 | 17.97 |
| Oman | Al-Lawati et al. (2015) | U/R | 11154 | ≥20 | 13.08 |
| Pooled prevalence: fixed effect | 26 | ||||
| Pooled prevalence: random effect | 24 | ||||
| Non-GCC states in the Middle East | |||||
| Lebanon | Ghassibe-Sabbagh et al. (2014) | U/R | 1,041 | ≥55 | 26.41 |
| Cyprus | Panagiotakos, Polystipioti, and Polychronopoulos (2007) | U/R | 53 | ≥65 | 26.00 |
| Iraq | Mansour, Al-Maliky, Kasem, Jabar, and Mosbeh (2014) | U/R | 2,577 | ≥20 | 19.60 |
| Jordan | Ajlouni, Khader, Batieha, Ajlouni, and El-Khateeb (2008) | U/R | 394 | ≥25 | 18.27 |
| Palestine | Abu-Rmeileh, Husseini, Capewell, and O’Flaherty (2013) | U/R | 336,965 | ≥25 | 16.90 |
| Turkey | Satman et al. (2013) | U/R | 9,327 | ≥20 | 16.00 |
| Syria | Albache et al. (2010) | U/R | 557 | ≥25 | 15.60 |
| Israel | Jaffe et al. (2017) | U/R | 16,358 | ≥20 | 13.70 |
| Egypt | Assaad et al. (2018) | U/R | 3,795 | 18–90 | 12.70 |
| Iran | Esteghamati et al. (2014) | U/R | 11,867 | 25–70 | 9.90 |
| Yemen | Gunaid and Assabri (2008) | U/R | 123 | >35 | 9.80 |
| Pooled prevalence: fixed effect | 17.00 | ||||
| Pooled prevalence: random effect | 16 | ||||
Note. DM = diabetes mellitus; GCC = Gulf Cooperation Council; UAE = United Arab Emirates; U/R = urban/rural.
Pooled prevalence fixed and random effect has been recorded for both GCC and Non GCC states.